Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Diroximel Fumarate Demonstrates an Improved Gastrointestinal Tolerability Profile Compared with Dimethyl Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis: Results from the Randomized, Double-Blind, Phase III EVOLVE-MS-2 Study.
Naismith RT, Wundes A, Ziemssen T, Jasinska E, Freedman MS, Lembo AJ, Selmaj K, Bidollari I, Chen H, Hanna J, Leigh-Pemberton R, Lopez-Bresnahan M, Lyons J, Miller C, Rezendes D, Wolinsky JS; EVOLVE-MS-2 Study Group. Naismith RT, et al. Among authors: rezendes d. CNS Drugs. 2020 Feb;34(2):185-196. doi: 10.1007/s40263-020-00700-0. CNS Drugs. 2020. PMID: 31953790 Free PMC article. Clinical Trial.
Diroximel fumarate (DRF) in patients with relapsing-remitting multiple sclerosis: Interim safety and efficacy results from the phase 3 EVOLVE-MS-1 study.
Naismith RT, Wolinsky JS, Wundes A, LaGanke C, Arnold DL, Obradovic D, Freedman MS, Gudesblatt M, Ziemssen T, Kandinov B, Bidollari I, Lopez-Bresnahan M, Nangia N, Rezendes D, Yang L, Chen H, Liu S, Hanna J, Miller C, Leigh-Pemberton R. Naismith RT, et al. Among authors: rezendes d. Mult Scler. 2020 Nov;26(13):1729-1739. doi: 10.1177/1352458519881761. Epub 2019 Nov 4. Mult Scler. 2020. PMID: 31680631 Free PMC article.
Pharmacological profile of ALKS 7119, an investigational compound evaluated for the treatment of neuropsychiatric disorders, in healthy volunteers.
Dijkstra FM, Zuiker RGJA, Siebenga PS, Leigh-Pemberton RA, Sun L, Manthis JD, de Kam ML, Lin R, von Moltke LL, Rezendes D, van Gerven JMA. Dijkstra FM, et al. Among authors: rezendes d. Br J Clin Pharmacol. 2022 Jun;88(6):2909-2925. doi: 10.1111/bcp.15229. Epub 2022 Jan 31. Br J Clin Pharmacol. 2022. PMID: 35014069 Free PMC article.
SNAPSHOT USA 2020: A second coordinated national camera trap survey of the United States during the COVID-19 pandemic.
Kays R, Cove MV, Diaz J, Todd K, Bresnan C, Snider M, Lee TE Jr, Jasper JG, Douglas B, Crupi AP, Weiss KCB, Rowe H, Sprague T, Schipper J, Lepczyk CA, Fantle-Lepczyk JE, Davenport J, Zimova M, Farris Z, Williamson J, Fisher-Reid MC, Rezendes D, King SM, Chrysafis P, Jensen AJ, Jachowski DS, King KC, Herrera DJ, Moore S, van der Merwe M, Lombardi JV, Sergeyev M, Tewes ME, Horan RV 3rd, Rentz MS, Driver A, Brandt RSE, Nagy C, Alexander P, Maher SP, Darracq AK, Barr EG, Hess G, Webb SL, Proctor MD, Vanek JP, Lafferty DJR, Hubbard T, Jiménez JE, McCain C, Favreau J, Fogarty J, Hill J, Hammerich S, Gray M, Rega-Brodsky CC, Durbin C, Flaherty EA, Brooke J, Coster SS, Lathrop RG, Russell K, Bogan DA, Shamon H, Rooney B, Rockhill A, Lonsinger RC, O'Mara MT, Compton JA, Barthelmess EL, Andy KE, Belant JL, Petroelje T, Wehr NH, Beyer DE Jr, Scognamillo DG, Schalk C, Day K, Ellison CN, Ruthven C, Nunley B, Fritts S, Whittier CA, Neiswenter SA, Pelletier R, DeGregorio BA, Kuprewicz EK, Davis ML, Baruzzi C, Lashley MA, McDonald B, Mason D, Risch DR, Allen ML, Whipple LS, Sperry JH, Alexander E, Wolff PJ, Hagen RH, Mortelliti A, Bolinjcar A, Wilson AM, Van Norman S, Powell C, Coletto H, … See abstract for full author list ➔ Kays R, et al. Among authors: rezendes d. Ecology. 2022 Oct;103(10):e3775. doi: 10.1002/ecy.3775. Epub 2022 Jul 24. Ecology. 2022. PMID: 35661139 Free PMC article.